EX-99.1 2 exh_991.htm EXHIBIT 99.1

Exhibit 99.1

 

FINANCIAL REVIEW OF MAGNA INTERNATIONAL INC. 
(United States dollars in millions, except per share figures) (Unaudited)
Prepared in accordance with U.S. GAAP
          2021   2022   2023
      Note   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q TOTAL
VEHICLE VOLUME STATISTICS (in millions)                    
North America     3.752 3.213 2.921 3.219 13.105   3.621 3.551 3.607 3.524 14.303   3.883 4.085 3.874 11.842
                                         
  Western Europe     3.045 2.443 1.783 2.392 9.663   2.491 2.596 2.292 2.704 10.083   3.021 2.972 2.521 8.514
  Eastern Europe     1.870 1.671 1.212 1.650 6.403   1.509 1.404 1.301 1.485 5.699   1.551 1.631 1.567 4.749
Total Europe     4.915 4.114 2.995 4.042 16.066   4.000 4.000 3.593 4.189 15.782   4.572 4.603 4.088 13.263
                                         
China     6.032 5.699 5.437 7.366 24.534   6.365 5.487 7.230 7.260 26.342   5.942 6.815 7.108 19.865
                                         
Other     6.955 5.819 5.291 6.087 24.152   6.331 6.127 6.710 6.866 26.034   7.040 6.781 6.867 20.688
                                         
Global     21.654 18.845 16.644 20.714 77.857   20.317 19.165 21.140 21.839 82.461   21.437 22.284 21.937 65.658
                                         
Magna Steyr vehicle assembly volumes     0.041 0.030 0.025 0.034 0.130   0.026 0.032 0.026 0.028 0.112   0.034 0.027 0.023 0.084
                                         
AVERAGE FOREIGN EXCHANGE RATES                                    
1 Canadian dollar equals U.S. dollars     0.790 0.814 0.794 0.794 0.798   0.790 0.783 0.765 0.737 0.769   0.740 0.745 0.746 0.744
1 Euro equals U.S. dollars     1.205 1.206 1.178 1.144 1.183   1.123 1.064 1.006 1.019 1.053   1.073 1.089 1.088 1.083
1 Chinese renminbi equals U.S. dollars     0.154 0.155 0.155 0.156 0.155   0.158 0.151 0.146 0.140 0.149   0.146 0.143 0.138 0.142
                                         
CONSOLIDATED STATEMENTS OF INCOME (LOSS)                                    
Sales:                                      
    Body Exteriors & Structures      4,025      3,647      3,185      3,620 14,477   4,077     3,947     3,976     4,004 16,004   4,439     4,540      4,354 13,333
    Power & Vision     3,156      2,881      2,501      2,804 11,342   3,046     2,888     2,911     3,016 11,861   3,323     3,462      3,745 10,530
    Seating Systems     1,303 1,166 1,123 1,299 4,891   1,376 1,253 1,295 1,345 5,269   1,486 1,603 1,529 4,618
    Complete Vehicles     1,850 1,490 1,255 1,511 6,106   1,275 1,403 1,213 1,330 5,221   1,626 1,526 1,185 4,337
    Corporate & Other     (155) (150) (145) (124) (574)   (132) (129) (127) (127) (515)   (201) (149) (125) (475)
Sales     10,179      9,034      7,919      9,110 36,242   9,642     9,362     9,268     9,568 37,840   10,673   10,982    10,688 32,343
                                         
Costs and expenses:                                    
  Cost of goods sold     8,662      7,728      6,885      7,822 31,097   8,400     8,259     8,126     8,403 33,188   9,416     9,544      9,264 28,224
  Selling, general and administrative      430         419         454         414 1,717   386        410        387        477 1,660   488        505         491 1,484
  Equity income     (47)         (44)         (34)         (23) (148)   (20)         (25)         (27)         (17) (89)   (33)         (36)          (40) (109)
                                         
Adjusted EBITDA     1,134 931 614 897 3,576   876 718 782 705 3,081   802 969 973 2,744
  Depreciation     352         362         373         377 1,464   357        348        330        338 1,373   353        353         358 1,064
                                         
Adjusted EBIT     782 569 241 520 2,112   519 370 452 367 1,708   449 616 615 1,680
  Amortization of acquired intangible assets     12 12 12 12 48   12 12 11 11 46   12 13 32 57
  Other expense (income), net 1   (58) 6 180 (90) 38   61 426 23 193 703   142 86 (4) 224
  Interest expense, net     23           11           22           22 78   26          20          18          17 81   20          34           49 103
                                         
Income (loss) from operations before income taxes     805 540 27 576 1,948   420 (88) 400 146 878   275 483 538 1,296
Income tax expense     183         104           10           98 395   41          57        104          35 237   58        129         121 308
                                         
Net income (loss)     622         436           17         478 1,553   379       (145)        296        111 641   217        354         417 988
(Income) loss attributable to non-controlling interests     (7)         (12)           (6)         (14) (39)   (15)         (11)           (7)         (16) (49)   (8)         (15)          (23) (46)
                                         
Net income (loss) attributable to Magna International Inc.     615 424 11 464 1,514   364 (156) 289 95 592   209 339 394 942
                                         
Diluted earnings (loss) per common share:      $    2.03  $    1.40  $    0.04  $    1.54  $    5.00    $   1.22  $  (0.54)  $   1.00  $   0.33  $   2.03    $   0.73  $   1.18  $    1.37  $   3.29
                                         
Weighted average number of Common Shares outstanding                                     
  during the period (in millions):     303.6 303.6 302.6 301.5 302.8   298.1 291.1 288.5 286.3 291.2   286.6 286.3 286.8 286.6
                                         
NON-GAAP MEASURES                                    
                                         
  Adjusted EBITDA     1,134 931 614 897 3,576   876 718 782 705 3,081   802 969 973 2,744
                                         
  Adjusted EBIT 2   782 569 241 520 2,112   519 370 452 367 1,708   449 616 615 1,680
                                         
  Adjusted net income attributable to Magna International Inc.     575 434 179 399 1,587   393 253 317 270 1,233   329 441 419 1,189
                                         
  Adjusted Diluted earnings (loss) per common share      $    1.89  $    1.43  $    0.59  $    1.32  $    5.24    $   1.32  $   0.87  $   1.10  $   0.94  $   4.24    $   1.15  $   1.54  $    1.46  $   4.15
                                         
                                         
PROFITABILITY RATIOS                                    
  Selling, general and administrative /Sales     4.2% 4.6% 5.7% 4.5% 4.7%   4.0% 4.4% 4.2% 5.0% 4.4%   4.6% 4.6% 4.6% 4.6%
  Adjusted EBIT /Sales     7.7% 6.3% 3.0% 5.7% 5.8%   5.4% 4.0% 4.9% 3.8% 4.5%   4.2% 5.6% 5.8% 5.2%
  Operating income /Sales     7.9% 6.0% 0.3% 6.3% 5.4%   4.4% -0.9% 4.3% 1.5% 2.3%   2.6% 4.4% 5.0% 4.0%
  Effective tax rate                                    
    Reported     22.7% 19.3% 37.0% 17.0% 20.3%   9.8% -64.8% 26.0% 24.0% 27.0%   21.1% 26.7% 22.5% 23.8%
    Excluding Other expense (income) and amortization, net of taxes     23.3% 20.1% 15.5% 17.1% 20.1%   17.2% 24.6% 25.3% 18.3% 21.2%   21.4% 21.6% 21.9% 21.7%

 

 Page 1 of 6 

 

FINANCIAL REVIEW OF MAGNA INTERNATIONAL INC.
CONSOLIDATED BALANCE SHEETS
(United States dollars in millions) (Unaudited)
                                     
        2021     2022     2023
        1st Q 2nd Q 3rd Q 4th Q     1st Q 2nd Q 3rd Q 4th Q     1st Q 2nd Q 3rd Q
FUNDS EMPLOYED                                
Current assets:                                
  Accounts receivable   7,176      6,531      6,082      6,307     7,006     6,764     7,082     6,791     7,959     8,556      8,477
  Inventories   3,645      3,999      4,150      3,969     4,258     4,064     4,108     4,180     4,421     4,664      4,751
  Prepaid expenses and other   290         294         247         278     310        262        269        320     367        455         387
           11,111    10,824    10,479    10,554       11,574   11,090   11,459   11,291       12,747   13,675    13,615
Current liabilities:                                
  Accounts payable   6,787      6,248      5,914      6,465     6,845     6,443     6,624     6,999     7,731     7,984      7,911
  Accrued salaries and wages   897         912         893         851     879        766        810        850     822        858         900
  Other accrued liabilities   2,298      2,186      2,070      2,156     2,123     2,096     1,986     2,118     2,526     2,637      2,537
  Income taxes payable (receivable)   109         123         125         200     190        136          97          93     9         (14)           33
        10,091      9,469      9,002      9,672     10,037     9,441     9,517   10,060     11,088   11,465    11,381
                                     
Working capital    1,020      1,355      1,477         882     1,537     1,649     1,942     1,231     1,659     2,210      2,234
                                     
Investments           960      1,124      1,455      1,593         1,487     1,375     1,323     1,429         1,390     1,287      1,311
Fixed assets, net        8,305      8,297      8,166      8,293         8,090     7,723     7,470     8,173         8,304     8,646      8,778
Goodwill, other assets and intangible assets   3,614      3,632      3,530      3,577     3,544     3,353     3,280     3,576     3,640     4,733      4,726
Operating lease right-of-use assets        1,869      1,854      1,731      1,700         1,667     1,587     1,545     1,595         1,638     1,667      1,696
Funds employed      15,768    16,262    16,359    16,045       16,325   15,687   15,560   16,004       16,631   18,543    18,745
FINANCING                                
Straight debt:                                
  Cash and cash equivalents   (3,464)    (3,426)    (2,748)    (2,948)     (1,996)    (1,664)    (1,102)    (1,234)     (2,429)    (1,281)     (1,022)
  Short-term borrowings   -             -             -             -     -             -             -            8     4        150             2
  Long-term debt due within one year   137         117         101         455     127        105          95        654     668     1,426      1,398
  Long-term debt   3,935      3,941      3,908      3,538     3,501     3,408     3,325     2,847     4,500     4,159      4,135
  Current portion of operating lease liabilities   244         278         269         274     276        270        266        276     285        303         384
  Operating lease liabilities   1,613      1,563      1,438      1,406         1,369     1,294     1,254     1,288         1,318     1,345      1,289
             2,465      2,473      2,968      2,725         3,277     3,413     3,838     3,839         4,346     6,102      6,186
Long-term employee benefit liabilities   733         743         716         700     686        651        617        548     563        579         564
Other long-term liabilities   414         482         466         376     374        390        397        461     451        448         453
Deferred tax liabilities, net   104         124           40           19     (51)       (111)       (138)       (179)     (218)       (242)        (210)
             1,251      1,349      1,222      1,095         1,009        930        876        830            796        785         807
Shareholders' equity   12,052    12,440    12,169    12,225     12,039   11,344   10,846   11,335     11,489   11,656    11,752
           15,768    16,262    16,359    16,045       16,325   15,687   15,560   16,004       16,631   18,543    18,745
                                               
ASSET UTILIZATION RATIOS                                
  Days in accounts receivable   63.4 65.1 69.1 62.3     65.4 65.0 68.8 63.9     67.1 70.1 71.4
  Days in accounts payable   70.5 72.8 77.3 74.4     73.3 70.2 73.4 75.0     73.9 75.3 76.9
  Inventory turnover - cost of sales   9.5 7.7 6.6 7.9     7.9 8.1 7.9 8.0     8.5 8.2 7.8
  Working capital turnover    39.9 26.7 21.4 41.3     25.1 22.7 19.1 31.1     25.7 19.9 19.1
  Total asset turnover    2.6 2.2 1.9 2.3     2.4 2.4 2.4 2.4     2.6 2.4 2.3
                                     
CAPITAL STRUCTURE                                
  Straight debt   15.6% 15.2% 18.1% 17.0%     20.1% 21.8% 24.7% 24.0%     26.1% 32.9% 33.0%
  Long-term employee benefit liabilities, other long-term                                
    liabilities & deferred tax liabilities, net   7.9% 8.3% 7.5% 6.8%     6.2% 5.9% 5.6% 5.2%     4.8% 4.2% 4.3%
  Shareholders' equity    76.4% 76.5% 74.4% 76.2%     73.7% 72.3% 69.7% 70.8%     69.1% 62.9% 62.7%
        100.0% 100.0% 100.0% 100.0%     100.0% 100.0% 100.0% 100.0%     100.0% 100.0% 100.0%
                                     
  Debt to total capitalization    33.0% 32.2% 32.0% 31.7%     30.5% 30.9% 31.3% 30.9%     37.1% 38.8% 38.0%
                                     
ANNUALIZED RETURNS                                
  Return on equity (Net income attributable to Magna                                
    International Inc. / Average shareholders' equity)   20.7% 13.8% 0.4% 15.2%     12.0% -5.3% 10.4% 3.4%     7.3% 11.7% 13.5%
  Adjusted Return on equity (Adjusted Net income attributable                                
     to Magna International Inc. / Average shareholders' equity)   19.4% 14.2% 5.8% 13.1%     13.0% 8.7% 11.4% 9.7%     11.5% 15.2% 14.3%
  Return on Invested Capital (Annualized after-tax operating                                
    profits / invested capital)   16.3% 11.1% 0.9% 12.2%     9.9% -3.2% 7.9% 3.2%     5.7% 8.7% 9.8%
  Adjusted Return on Invested Capital (Adjusted Annualized after-tax                                
    operating profits / invested capital)   15.3% 11.4% 5.0% 10.6%     10.6% 7.0% 8.6% 7.6%     8.7% 11.0% 10.3%

 

 Page 2 of 6 

 

FINANCIAL REVIEW OF MAGNA INTERNATIONAL INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(United States dollars in millions) (Unaudited)
                                             
              2021   2022   2023
Cash provided from (used for): Note   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q TOTAL
                             
Operating activities                                    
  Net income (loss)             622         436           17         478      1,553          379       (145)        296        127        657          217        354         417        988
  Items not involving current cash flows (i)           349         341         515         371      1,576          370        705        295        406     1,776          351        525         404     1,280
          (i)           971         777         532         849      3,129          749        560        591        533     2,433          568        879         821     2,268
  Changes in operating assets and liabilities (i)         (310)       (249)       (132)         502       (189)         (569)       (139)       (353)        723       (338)         (341)       (332)          (24)       (697)
Cash provided from operating activities             661         528         400      1,351      2,940          180        421        238     1,256     2,095          227        547         797     1,571
                                                   
Investment activities                                          
  Fixed asset additions            (212)       (277)       (334)       (549)    (1,372)         (238)       (329)       (364)       (750)    (1,681)         (424)       (502)        (630)    (1,556)
  Increase in equity method investment                -              -         (454)         (63)       (517)              -              -              -              -              -                -              -               -              -  
  Increase in investments, other assets and intangible assets           (104)         (93)       (101)       (105)       (403)           (64)         (80)       (125)       (186)       (455)         (101)         (96)        (176)       (373)
  Net cash (outflow) inflow from disposal of facilities 1(c), 1(f)              -              -           (41)            -           (41)              6            -              -              -              6           (25)            -            (23)         (48)
  Increase in public and private equity investments               (3)         (17)           (3)         (45)         (68)             (2)           (2)         (25)            -           (29)              -             (3)            (7)         (10)
  Settlement of long-term receivable from non-consolidated joint venture             50            -              -              -             50              -              -              -              -              -                -              -               -              -  
  Proceeds from disposition               19           20           10           32           81            23          40          41          20        124            19          44           32          95
  Business combinations               39         (21)            -           (31)         (13)              -              -              -             (3)           (3)              -      (1,475)             -      (1,475)
Cash used for investment activities           (211)       (388)       (923)       (761)    (2,283)         (275)       (371)       (473)       (919)    (2,038)         (531)    (2,032)        (804)    (3,367)
                                                   
Financing activities                                          
  Net issues (repayments) of debt           (126)         (33)         (13)             5       (167)         (328)         (31)         (10)         (22)       (391)       1,636        544        (135)     2,045
  Common Shares issued on exercise of stock options               83           50             3           10         146              4            -              1            3            8              6            -               8          14
  Repurchase of Common Shares           (162)         (99)           (5)       (251)       (517)         (383)       (212)       (180)           (5)       (780)             (9)           (2)             -           (11)
  Tax withholdings on vesting of equity awards             (12)            -              -             (1)         (13)           (14)           (1)            -              -           (15)             (9)           (1)             -           (10)
  Contributions to subsidiaries by non-controlling interests                -              -              -               8             8              -              5            -              -              5              -              -               -              -  
  Dividends paid to non-controlling interests                -             (8)           (2)         (39)         (49)              -           (12)         (10)         (24)         (46)             (7)         (24)          (18)         (49)
  Dividends paid           (130)       (127)       (130)       (127)       (514)         (133)       (130)       (125)       (126)       (514)         (132)       (129)        (128)       (389)
Cash provided from (used for) financing activities           (347)       (217)       (147)       (395)    (1,106)         (854)       (381)       (324)       (174)    (1,733)       1,485        388        (273)     1,600
Effect of exchange rate changes on cash, cash equivalents                                          
  and restricted cash equivalents             (13)           39           (8)             5           23             (3)           (1)           (3)         (31)         (38)            14         (51)           21         (16)
Net increase (decrease) in cash, cash equivalents                                    
  and restricted cash equivalents during the period               90         (38)       (678)         200       (426)         (952)       (332)       (562)        132    (1,714)       1,195    (1,148)        (259)       (212)
Cash, cash equivalents and restricted cash equivalents,                                    
  beginning of period          3,374      3,464      3,426      2,748      3,374       2,948     1,996     1,664     1,102     2,948       1,234     2,429      1,281     1,234
Cash, cash equivalents and restricted cash equivalents,                                          
  end of period          3,464      3,426      2,748      2,948      2,948       1,996     1,664     1,102     1,234     1,234       2,429     1,281      1,022     1,022
                                             
        (i) Certain amounts in prior periods have been reclassified to conform with current period presentation.

 

 Page 3 of 6 

 

FINANCIAL REVIEW OF MAGNA INTERNATIONAL INC.
(United States dollars in millions, except per share figures) (Unaudited)
    This Analyst should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2022.
                                             
Note 1:  OTHER EXPENSE (INCOME), NET
    Other expense (income), net consists of:
              2021   2022   2023
              1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q TOTAL
                                             
    Investment revaluations, (gains) losses on sales, and impairments [a]   (33) (38) 81 (8) 2   61 50 9 101 221   24 98 (19) 103
    Restructuring [b]   15 44 12 18 89   - - - 22 22   118 (35) (1) 82
    Operations in Russia [c]   - - - - -   - 376 - - 376   - - 16 16
    Veoneer related termination fees and transaction costs [d]   - - - (100) (100)   - - - - -   - 23 - 23
    Impairments [e]   - - 12 - 12   - - 14 12 26   - - - -
    Loss on sale of business [f]   - - 75 - 75   - - - 58 58   - - - -
    Gain on business combinations [g]   (40) - - - (40)   - - - - -   - - - -
                                                    -    
              (58)             6         180         (90)           38   61        426          23        193        703   142          86            (4)        224
  [a] Investment revaluations, (gains) losses on sales, and impairments                                  
    The Company revalues its public and private equity investments and certain public company warrants every quarter. The gains and losses related to this revaluation, as well as gain and losses on disposition, are recorded in Corporate. In the second quarter of 2023, the Company recorded a non-cash impairment charge of $85 million on a private equity investment and related long-term receivables within Other assets in its Corporate segment.  
     
  [b] Restructuring
    Reversal of restructuring charges:
    During the second quarter of 2023, the Company’s Power & Vision segment reversed $39 million of charges due to a change in the restructuring plans related to a plant closure.
     
    Sale of buildings as a result of restructuring activities:
    During the second and third quarter of 2023, the Company’s Power & Vision segment recorded a $10 million and $8 million gain on the sale of a building as a result of restructuring activities, respectively.
     
    Other Restructuring:     2021   2022   2023
              1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q TOTAL
    Power & Vision               15           44             4             4           67               -             -             -          22          22          105            5             7        117
    Body Exteriors & Structures                 -             -             8             -             8               -             -             -             -             -            13            9              -          22
    Seating Systems     - - - 14 14   - - - - -   - - - -
              15           44           12           18           89   -             -             -          22 22   118          14             7 139
  [c] Operations in Russia                                    
    As a result of the expected lack of future cashflows and the continuing uncertainties connected with the Russian economy, during the second quarter of 2022, the Company recorded a $376 million impairment charge related to its investment in Russia. This included net asset impairments of $173 million and a $203 million reserve against the related foreign currency translation losses that were included in accumulated other comprehensive loss. The net asset impairments consisted of $163 million and $10 million in our Body Exteriors & Structures and our Seating Systems segments, respectively.

During the third quarter of 2023, the Company completed the sale of all of its investments in Russia resulting in a loss of $16 million including a net cash outflow of $23 million.
     
  [d] Veoneer related termination fees and transaction costs
    During 2023, the Company incurred $23 million of transaction costs related to the acquisition of the Veoneer Active Safety Business.

In the fourth quarter of 2021, Veoneer, Inc. (“Veoneer”) terminated its merger agreement with Magna.  In connection with the termination of the merger agreement, Veoneer paid the Company a termination fee which, net of the Company’s associated transaction costs, amounted to $100 million.
     
  [e] Impairments     2021   2022   2023
              1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q TOTAL
    Body Exteriors & Structures                 -             -             8             -             8               -             -          10          12          22               -             -              -             -
    Power & Vision                 -             -             -             -             -               -             -            4             -            4               -             -              -             -
    Seating Systems     - - 4 - 4   - - - - -   - - - -
              -             -           12             -           12   -             -          14          12 26   -             -              - -
  [f] Loss on sale of business                                    
    During the fourth quarter of 2022, the Company entered into an agreement to sell a European Power & Vision operation. Under the terms of the arrangement, the Company is contractually obligated to provide the buyer with up to $42 million of funding, resulting in a loss of $58 million. During the first quarter of 2023, the Company completed the sale of this operation which resulted in a net cash outflow of $25 million.

During the third quarter of 2021, the Company sold three Body Exteriors & Structures operations in Germany. Under the terms of the arrangement, the Company provided the buyer with $41 million of funding, resulting in a loss on disposal of $75 million.
     
  [g] Gain on business combinations
    In Seating Systems, during the first quarter of 2021, the Company recognized a $22 million gain on the on the change in basis of accounting for its previously held equity method investments. Also during the first quarter of 2021, in Power & Vision, substantially all of the assets of the Company's European joint venture with Ford Motor Company, Getrag Ford Transmission GmbH, were distributed to either Ford or the Company, which resulted in the Company recording a gain of $18 million.

 

 Page 4 of 6 

 

Note 2:  NON-GAAP MEASURES
    The Company presents Adjusted EBIT (Earnings before interest, taxes, Other expense (income),net, and amortization of acquired intangible assets), Adjusted Net Income (Net Income before Other expense (income),net, net of tax excluding significant income tax valuation allowance adjustments, and amortization of acquired intangible assets), Adjusted Diluted Earnings per Share and Adjusted EBIT as a percentage of sales, Adjusted Return on Invested Capital and Adjusted Return on Equity. Effective July 1, 2023, the Company revised its calculation of Adjusted EBIT, Adjusted diluted earnings per share and Adjusted Return on Invested Capital to exclude the amortization of acquired intangibles assets. The Company presents these financial figures because such measures are widely used by analysts and investors in evaluating the operating performance of the Company.  However, such measures do not have any standardized meaning under U.S. generally accepted accounting principles and may not be comparable to the calculation of similar measures by other companies. Adjusted EBIT, Adjusted Net Income and Adjusted diluted earnings per share presented in the tables below, including for the prior period, have been updated to reflect the revised calculation.
     
    The following table reconciles Income (loss) from operations before income taxes to Adjusted EBIT:                          
                               
              2021   2022   2023
              1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q TOTAL
                                             
    Income (loss) from operations before income taxes     805         540           27         576 1,948   420         (88)        400        146 878   275        483         538 1,296
      Exclude:                                    
        Amortization of acquired intangible assets     12           12           12           12 48   12          12          11          11 46   12          13           32 57
        Other expense (income), net     (58)             6         180         (90) 38   61        426          23        193 703   142          86            (4) 224
        Interest expense     23           11           22           22 78   26          20          18          17 81   20          34           49 103
    Adjusted EBIT     782         569         241         520 2,112   519        370        452        367 1,708   449        616         615 1,680
                                             
    The following table reconciles Net income (loss) attributable to Magna International Inc. to Adjusted net income attributable to Magna International Inc.:
     
              2021   2022   2023
              1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q TOTAL
                                             
    Net income (loss) attributable to Magna International Inc.     615         424           11         464      1,514   364       (156)        289          95        592   209        339         394        942
      Exclude:                                     
        Investment revaluations, (gains) losses on sales, and impairments   (24) (29) 64 (2)             9   48 38 7 75        168   18 95 (14)          99
        Impairments     - - 9 -             9   - 361 12 12        385   - - -             -
        Operations in Russia     - - - -             -   - - - -             -   - - 16          16
        Amortization of acquired intangible assets     9 8 9 8           34   10 10 9 9          38   10 11 25          46
        Restructuring     15 31 11 17           74   - - - 22          22   92 (26) (2)          64
        Veoneer related termination fees and transaction costs     - - - (75)         (75)   - - - -             -   - 22 -          22
        Net losses on the sale of business     - - 75 -           75   - - - 57          57   - - -             -
        Adjustments to Deferred Tax Valuation Allowance [i]   - - - (13)         (13)   (29) - - -         (29)   - - -             -
        Gain on business combinations     (40) - - -         (40)   - - - -             -   - - -             -
    Adjusted net income attributable to Magna International Inc.     575         434         179         399      1,587   393        253        317        270     1,233   329        441         419     1,189
                                             
    The following table reconciles diluted earnings (loss) per common share to Adjusted diluted earnings (loss) per common share:
     
              2021   2022   2023
              1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q TOTAL
                                             
    Diluted earnings (loss) per common share      $    2.03  $    1.40  $    0.04  $    1.54  $    5.00    $   1.22  $  (0.54)  $   1.00  $   0.33  $   2.03    $   0.73       1.18        1.37  $   3.29
      Exclude:                                    
        Investment revaluations, (gains) losses on sales, and impairments   (0.08)      (0.10)        0.21      (0.01) 0.03   0.16       0.13       0.03       0.26 0.58   0.07       0.33       (0.06) 0.35
        Impairments     -            -          0.03            -   0.03   -       1.24       0.04       0.04 1.32   -            -               -   -
        Operations in Russia     -            -              -              -   -   -            -              -              -   -   -            -          0.06 0.06
        Amortization of acquired intangible assets     0.03        0.04        0.03        0.02 0.11   0.04       0.03       0.03       0.03 0.13   0.04       0.04        0.09 0.15
        Restructuring     0.05        0.10        0.03        0.06 0.24   -            -              -         0.08 0.08   0.31      (0.09)             -   0.22
        Veoneer related termination fees and transaction costs     -            -              -        (0.25) (0.25)   -            -              -              -   -   -       0.08             -   0.08
        Net losses on the sale of business     -            -          0.25            -   0.25   -            -              -         0.20 0.20   -            -               -   -
        Adjustments to Deferred Tax Valuation Allowance [i]   -            -              -        (0.04) (0.04)   (0.10)            -              -              -   (0.10)   -            -               -   -
        Gain on business combinations     (0.14)            -              -              -   (0.13)   -            -              -              -   -   -            -               -   -
                                             
    Adjusted diluted earnings per common share       $    1.89  $    1.43  $    0.59  $    1.32  $    5.24    $   1.32  $   0.87  $   1.10  $   0.94  $   4.24    $   1.15  $   1.54  $    1.46  $   4.15
     
    [i] Adjustments to Deferred Tax Valuation Allowance
    In the fourth quarter of 2021, and first quarter of 2022, the Company recorded adjustments to the valuation allowance against its deferred tax assets in certain European countries and North America. The net effect of these adjustments was a reduction in income tax expense of $13 million and $29 million, respectively.

 

 Page 5 of 6 

 

Note 3:  SEGMENTED INFORMATION
     
              2021   2022   2023
              1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q 4th Q TOTAL   1st Q 2nd Q 3rd Q TOTAL
    Body Exteriors & Structures                     
      Sales     4,025 3,647 3,185 3,620 14,477   4,077 3,947 3,976 4,004 16,004   4,439 4,540 4,354 13,333
      Adjusted EBIT     329 230 100 171 830   231 194 227 200 852   272 394 358 1,024
      Adjusted EBIT as a percentage of sales     8.2% 6.3% 3.1% 4.7% 5.7%   5.7% 4.9% 5.7% 5.0% 5.3%   6.1% 8.7% 8.2% 7.7%
                                             
    Power & Vision                                    
      Sales     3,156 2,881 2,501 2,804 11,342   3,046 2,888 2,911 3,016 11,861   3,323 3,462 3,745 10,530
      Adjusted EBIT     306 210 77 178 771   163 99 124 116 502   92 124 221 437
      Adjusted EBIT as a percentage of sales     9.7% 7.3% 3.1% 6.3% 6.8%   5.4% 3.4% 4.3% 3.8% 4.2%   2.8% 3.6% 5.9% 4.2%
                                             
    Seating Systems                                    
      Sales     1,303 1,166 1,123 1,299 4,891   1,376 1,253 1,295 1,345 5,269   1,486 1,603 1,529 4,618
      Adjusted EBIT     56 28 22 51 157   50 3 37 14 104   37 67 70 174
      Adjusted EBIT as a percentage of sales     4.3% 2.4% 2.0% 3.9% 3.2%   3.6% 0.2% 2.9% 1.0% 2.0%   2.5% 4.2% 4.6% 3.8%
                                             
    Complete Vehicles                                    
      Sales     1,850 1,490 1,255 1,511 6,106   1,275 1,403 1,213 1,330 5,221   1,626 1,526 1,185 4,337
      Adjusted EBIT     80 79 30 98 287   50 63 65 57 235   52 34 (5) 81
      Adjusted EBIT as a percentage of sales     4.3% 5.3% 2.4% 6.5% 4.7%   3.9% 4.5% 5.4% 4.3% 4.5%   3.2% 2.2% -0.4% 1.9%
                                             
    Corporate and other                                    
      Intercompany eliminations     (155) (150) (145) (124) (574)   (132) (129) (127) (127) (515)   (201) (149) (125) (475)
      Adjusted EBIT     11 22 12 22 67   25 11 (1) (20) 15   (4) (3) (29) (36)
                                             
    Total                                      
      Sales     10,179 9,034 7,919 9,110 36,242   9,642 9,362 9,268 9,568 37,840   10,673 10,982 10,688 32,343
      Adjusted EBIT     782 569 241 520 2,112   519 370 452 367 1,708   449 616 615 1,680
      Adjusted EBIT as a percentage of sales     7.7% 6.3% 3.0% 5.7% 5.8%   5.4% 4.0% 4.9% 3.8% 4.5%   4.2% 5.6% 5.8% 5.2%

 

 

 

 

 

 

 

Page 6 of 6